Choosing the right dose for the right patient for stroke prevention
in non-valvular AF

Pradaxa® is the only NOAC that gives the physician the flexibility to select the appropriate dose for an individual patient. A reduced dose can be used at the HCP’s discretion when they are concerned the patient may have an increased risk of bleeding.1–3